Immunological tolerance to xenogeneic grafts induced by cyclophosphamide in adult animals. 1994

Chernyakhovskaya IYu, and L N Fontalin
N.F. Gamaleya Research Institute for Epidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow, Russia.

Data on tolerance of mice to rat tissue grafts obtained during the last 20 years are presented in this article. The method of tolerance induction, which spared recipients' lymphoid tissue and which needed no supporting antigen or immunodepressant injection, is described. These tolerant mice had long-lasting (more than 6 months) xenograft survival, had no cytotoxic antibodies and delayed-type hypersensitivity (DTH) reaction to donor antigens but showed only a partial decrease in the levels of mixed lymphocyte reaction (MLR) and non-cytotoxic antibody production. According to indirect evidence, tolerance arose as a result of clonal deletion and was maintained subsequently by antigen-specific T-suppressor cells and Thy-negative lymphocytes.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D017710 Lymphocyte Transfusion The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor. Lymphocyte Transfusions,Transfusion, Lymphocyte,Transfusions, Lymphocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Chernyakhovskaya IYu, and L N Fontalin
February 1995, Transplantation proceedings,
Chernyakhovskaya IYu, and L N Fontalin
December 1996, Nihon Geka Gakkai zasshi,
Chernyakhovskaya IYu, and L N Fontalin
July 1996, Immunobiology,
Chernyakhovskaya IYu, and L N Fontalin
April 1974, Transplantation,
Chernyakhovskaya IYu, and L N Fontalin
February 1967, Nature,
Chernyakhovskaya IYu, and L N Fontalin
January 1990, Fukuoka igaku zasshi = Hukuoka acta medica,
Chernyakhovskaya IYu, and L N Fontalin
February 1971, The Japanese journal of experimental medicine,
Chernyakhovskaya IYu, and L N Fontalin
January 1975, Folia biologica,
Chernyakhovskaya IYu, and L N Fontalin
August 1962, Biulleten' eksperimental'noi biologii i meditsiny,
Chernyakhovskaya IYu, and L N Fontalin
January 1973, Allergie und Immunologie,
Copied contents to your clipboard!